1. EP-1329: IG-SBRT for localized prostate cancer: clinical results and late toxicity of a phase-II study. (May 2017) Authors: Magli, A.; Moretti, E.; Tullio, A.; Foti, C.; Crespi, M.; Urpis, M.; Prisco, A.; Malisan, M.R. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Grafting after sinus lift with anorganic bovine bone alone compared with 50:50 anorganic bovine bone and autologous bone: results of a pilot randomised trial at one year. Issue 5 (May 2015) Authors: Meloni, S.M.; Jovanovic, S.A.; Lolli, F.M.; Cassisa, C.; De Riu, G.; Pisano, M.; Lumbau, A.; Lugliè, P.F.; Tullio, A. Journal: British journal of oral and maxillofacial surgery Issue: Volume 53:Issue 5(2015) Page Start: 436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC.09.5 LONG-TERM EFFECTIVENESS OF USTEKINUMAB IN PATIENTS WITH REFRACTORY CROHN'S DISEASE: A MULTICENTER REALLIFE STUDY. (September 2021) Authors: Scribano, M.L.; Aratari, A.; Neri, B.; Bezzio, C.; Balestrieri, P.; Falasco, G.; Camastra, C.; Pantanella, P.; Monterubbianesi, R.; Tullio, A.; Saibeni, S.; Papi, C.; Biancone, L.; Cosintino, R.; Faggiani, R. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. T.10.3 THE EFFECT OF VEDOLIZUMAB ON COLONIC MICROBIOTA COMPOSITION IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE. (March 2023) Authors: Altomare, A.; Rocchi, G.; Balestrieri, P.; Tullio, A.; Putignani, L.; Gori, M.; Guarino, M.P.L.; Cicala, M. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. T04.01.2 WALL THICKNESS RATIO, A NEW MAGNETIC RESONANCE PARAMETER, PREDICTS THE OUTCOME OF BIOLOGICAL THERAPY IN PATIENTS WITH ILEAL AND ILEOCOLONIC CROHN'S DISEASE. (1st October 2020) Authors: Balestrieri, P.; Ribolsi, M.; Tullio, A.; Solida, E.; Cicala, M. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗